FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:ABCB7-SH3BGRL

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: ABCB7-SH3BGRL
FusionPDB ID: 216
FusionGDB2.0 ID: 216
HgeneTgene
Gene symbol

ABCB7

SH3BGRL

Gene ID

22

6451

Gene nameATP binding cassette subfamily B member 7SH3 domain binding glutamate rich protein like
SynonymsABC7|ASAT|Atm1p|EST140535HEL-S-115|SH3BGR
Cytomap

Xq13.3

Xq21.1

Type of geneprotein-codingprotein-coding
DescriptionATP-binding cassette sub-family B member 7, mitochondrialABC transporter 7 proteinATP-binding cassette transporter 7ATP-binding cassette, sub-family B (MDR/TAP), member 7SH3 domain-binding glutamic acid-rich-like proteinSH3 domain binding glutamic acid-rich protein likeSH3-binding domain glutamic acid-rich protein likeepididymis secretory protein Li 115
Modification date2020032020200313
UniProtAcc

O75027

Main function of 5'-partner protein: FUNCTION: Could be involved in the transport of heme from the mitochondria to the cytosol. Plays a central role in the maturation of cytosolic iron-sulfur (Fe/S) cluster-containing proteins. {ECO:0000269|PubMed:10196363}.
.
Ensembl transtripts involved in fusion geneENST idsENST00000253577, ENST00000339447, 
ENST00000373394, ENST00000534570, 
ENST00000481106, ENST00000373212, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score2 X 2 X 2=87 X 4 X 5=140
# samples 27
** MAII scorelog2(2/8*10)=1.32192809488736log2(7/140*10)=-1
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: ABCB7 [Title/Abstract] AND SH3BGRL [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: ABCB7 [Title/Abstract] AND SH3BGRL [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)ABCB7(74375940)-SH3BGRL(80532483), # samples:1
Anticipated loss of major functional domain due to fusion event.ABCB7-SH3BGRL seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
ABCB7-SH3BGRL seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
ABCB7-SH3BGRL seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
ABCB7-SH3BGRL seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chrX:74375940/chrX:80532483)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across ABCB7 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across SH3BGRL (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000253577ABCB7chrX74375940-ENST00000373212SH3BGRLchrX80532483+181319325492155
ENST00000339447ABCB7chrX74375940-ENST00000373212SH3BGRLchrX80532483+17951757474155
ENST00000373394ABCB7chrX74375940-ENST00000373212SH3BGRLchrX80532483+17961768475155

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000253577ENST00000373212ABCB7chrX74375940-SH3BGRLchrX80532483+0.0022957050.9977043
ENST00000339447ENST00000373212ABCB7chrX74375940-SH3BGRLchrX80532483+0.0032664390.99673355
ENST00000373394ENST00000373212ABCB7chrX74375940-SH3BGRLchrX80532483+0.0035676140.9964324

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for ABCB7-SH3BGRL

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
ABCB7chrX74375940SH3BGRLchrX8053248317556HQLGALGTARAYQIKKKQQDVLGFLE
ABCB7chrX74375940SH3BGRLchrX8053248317656HQLGALGTARAYQIKKKQQDVLGFLE
ABCB7chrX74375940SH3BGRLchrX8053248319356HQLGALGTARAYQIKKKQQDVLGFLE

Top

Potential FusionNeoAntigen Information of ABCB7-SH3BGRL in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
ABCB7-SH3BGRL_74375940_80532483.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
ABCB7-SH3BGRLchrX74375940chrX80532483193HLA-B27:05ARAYQIKKK0.99880.7916817
ABCB7-SH3BGRLchrX74375940chrX80532483193HLA-A30:08TARAYQIKK0.99230.5717716
ABCB7-SH3BGRLchrX74375940chrX80532483193HLA-A30:08GTARAYQIK0.9770.7509615
ABCB7-SH3BGRLchrX74375940chrX80532483193HLA-A30:08GTARAYQIKK0.98570.5463616
ABCB7-SH3BGRLchrX74375940chrX80532483193HLA-B27:14ARAYQIKKK0.99780.7305817
ABCB7-SH3BGRLchrX74375940chrX80532483193HLA-B27:10ARAYQIKKK0.99830.868817
ABCB7-SH3BGRLchrX74375940chrX80532483193HLA-A30:01TARAYQIKK0.99080.7619716
ABCB7-SH3BGRLchrX74375940chrX80532483193HLA-A30:01GTARAYQIK0.97770.8727615
ABCB7-SH3BGRLchrX74375940chrX80532483193HLA-A30:01GTARAYQIKK0.98580.7211616
ABCB7-SH3BGRLchrX74375940chrX80532483193HLA-B15:30YQIKKKQQDVL0.97660.72891122

Top

Potential FusionNeoAntigen Information of ABCB7-SH3BGRL in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
ABCB7-SH3BGRL_74375940_80532483.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0801ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0801TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0801GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0803ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0803TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0803GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0805ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0805TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0805GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0808ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0808TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0811ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0811TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0814ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0814TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0814GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0816ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0816TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0816GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0818ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0818TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0818GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0823ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0823TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0823GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0826ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0826TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0826GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0827ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0827TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0827GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0829ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0829TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0829GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0833ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0833TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0833GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0835ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0835TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0835GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0836ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0836TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0836GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0837ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0837TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0837GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0837RAYQIKKKQQDVLGF924
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0837LGTARAYQIKKKQQD520
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0838ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0838TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0838GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0839ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0839TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0839GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0840ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0840TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0840GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-0906LGALGTARAYQIKKK217
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1108ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1111ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1111TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1111GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1111RAYQIKKKQQDVLGF924
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1114ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1114TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1114GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1119ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1119TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1120ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1120TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1120GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1131ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1131TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1132ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1132TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1145ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1145TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1145GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1145RAYQIKKKQQDVLGF924
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1164ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1164TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1164GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1168ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1168TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1168GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1168RAYQIKKKQQDVLGF924
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1169ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1172ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1173ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1182ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1186ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1186TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1186GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1302ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1302TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1302GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1303ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1303TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1303GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-13101ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-13101TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-13101GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-13101RAYQIKKKQQDVLGF924
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1310ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1310TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1310GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1310RAYQIKKKQQDVLGF924
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1312ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1312TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1312GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1313ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1313TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1313GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1313RAYQIKKKQQDVLGF924
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1313LGTARAYQIKKKQQD520
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1316ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1316TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1316GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1321ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1321TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1321GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1321RAYQIKKKQQDVLGF924
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1321LGTARAYQIKKKQQD520
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1323ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1323TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1323GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1329ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1329TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1329GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1329RAYQIKKKQQDVLGF924
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1330ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1330TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1330GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1330RAYQIKKKQQDVLGF924
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1330LGTARAYQIKKKQQD520
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1333ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1333TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1334ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1334TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1334GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1336ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1336TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1336GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1336RAYQIKKKQQDVLGF924
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1338ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1338TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1338GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1338RAYQIKKKQQDVLGF924
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1338LGTARAYQIKKKQQD520
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1339ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1339TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1339GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1341ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1341TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1341GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1349ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1349TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1349GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1355ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1355TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1355GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1355RAYQIKKKQQDVLGF924
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1356ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1363ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1363TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1363GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1363RAYQIKKKQQDVLGF924
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1365ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1365TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1365GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1365RAYQIKKKQQDVLGF924
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1365LGTARAYQIKKKQQD520
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1366ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1366TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1366GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1366RAYQIKKKQQDVLGF924
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1366LGTARAYQIKKKQQD520
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1373ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1373TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1373GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1374ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1374TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1374GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1375ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1382ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1382TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1388ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1388TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1388GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1390ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1390TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1390GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1395ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1395TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1395GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1396ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1397ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1397TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1397GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1399ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1399TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1399GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1422ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1422TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1425ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1425TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1453ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1453TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1453GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1463ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1463TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1463GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1463RAYQIKKKQQDVLGF924
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1463LGTARAYQIKKKQQD520
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1467ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1469ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1485ARAYQIKKKQQDVLG823
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1485TARAYQIKKKQQDVL722
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1485GTARAYQIKKKQQDV621
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1485RAYQIKKKQQDVLGF924
ABCB7-SH3BGRLchrX74375940chrX80532483193DRB1-1485LGTARAYQIKKKQQD520

Top

Fusion breakpoint peptide structures of ABCB7-SH3BGRL

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
3163GTARAYQIKKKQQDABCB7SH3BGRLchrX74375940chrX80532483193

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of ABCB7-SH3BGRL

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN3163GTARAYQIKKKQQD-7.15543-7.26883
HLA-B14:023BVN3163GTARAYQIKKKQQD-4.77435-5.80965
HLA-B52:013W393163GTARAYQIKKKQQD-6.80875-6.92215
HLA-B52:013W393163GTARAYQIKKKQQD-4.20386-5.23916
HLA-A11:014UQ23163GTARAYQIKKKQQD-7.5194-8.5547
HLA-A11:014UQ23163GTARAYQIKKKQQD-6.9601-7.0735
HLA-A24:025HGA3163GTARAYQIKKKQQD-7.52403-7.63743
HLA-A24:025HGA3163GTARAYQIKKKQQD-5.82433-6.85963
HLA-B27:056PYJ3163GTARAYQIKKKQQD-3.28285-4.31815
HLA-B44:053DX83163GTARAYQIKKKQQD-5.91172-6.94702
HLA-B44:053DX83163GTARAYQIKKKQQD-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of ABCB7-SH3BGRL

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
ABCB7-SH3BGRLchrX74375940chrX805324831122YQIKKKQQDVLTACCAGATTAAGAAGAAACAACAAGATGTGCTT
ABCB7-SH3BGRLchrX74375940chrX80532483615GTARAYQIKGGAACCGCTCGAGCCTACCAGATTAAG
ABCB7-SH3BGRLchrX74375940chrX80532483616GTARAYQIKKGGAACCGCTCGAGCCTACCAGATTAAGAAG
ABCB7-SH3BGRLchrX74375940chrX80532483716TARAYQIKKACCGCTCGAGCCTACCAGATTAAGAAG
ABCB7-SH3BGRLchrX74375940chrX80532483817ARAYQIKKKGCTCGAGCCTACCAGATTAAGAAGAAA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
ABCB7-SH3BGRLchrX74375940chrX80532483217LGALGTARAYQIKKKCTCGGCGCCTTGGGAACCGCTCGAGCCTACCAGATTAAGAAGAAA
ABCB7-SH3BGRLchrX74375940chrX80532483520LGTARAYQIKKKQQDTTGGGAACCGCTCGAGCCTACCAGATTAAGAAGAAACAACAAGAT
ABCB7-SH3BGRLchrX74375940chrX80532483621GTARAYQIKKKQQDVGGAACCGCTCGAGCCTACCAGATTAAGAAGAAACAACAAGATGTG
ABCB7-SH3BGRLchrX74375940chrX80532483722TARAYQIKKKQQDVLACCGCTCGAGCCTACCAGATTAAGAAGAAACAACAAGATGTGCTT
ABCB7-SH3BGRLchrX74375940chrX80532483823ARAYQIKKKQQDVLGGCTCGAGCCTACCAGATTAAGAAGAAACAACAAGATGTGCTTGGT
ABCB7-SH3BGRLchrX74375940chrX80532483924RAYQIKKKQQDVLGFCGAGCCTACCAGATTAAGAAGAAACAACAAGATGTGCTTGGTTTC

Top

Information of the samples that have these potential fusion neoantigens of ABCB7-SH3BGRL

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
STADABCB7-SH3BGRLchrX74375940ENST00000253577chrX80532483ENST00000373212TCGA-BR-8364-01A

Top

Potential target of CAR-T therapy development for ABCB7-SH3BGRL

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to ABCB7-SH3BGRL

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to ABCB7-SH3BGRL

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource